KRAS and adenoma: Incident cancer may represent a distinct early event, in which MMR-D commonly precedes APC mutations and the endoscopic removal of precursor lesions during surveillance may be more effective in preventing KRAS-mutated lesions [44], since KRAS mutations are associated with conventional adenomas [45].